Thoracic oncology

Respiratory tumours are a major part of daily practice for many respiratory physicians and lung cancer remains the biggest cancer killer in Europe, but there continues to be developments in surgical practice, treatments, and more recently, promising new targeted therapies.

This year's virtual Congress brings both the challenges and the latest developments in the field into focus through a variety of scientific and educational activities, which will be featured in a dedicated track for thoracic oncology.

To view all sessions included in this specialist track, you need to access the online programme, click on 'Advanced' and select 'Thoracic oncology' from the ‘Diseases’ options. The programme can also be used to search for keywords, speakers and dates and to build your customised Congress agenda.

Hear from the ERS Thoracic Oncology Assembly

We spoke to ERS officers who specialise in thoracic oncology to find out what you can expect from the virtual Congress and which programme highlights you should not miss. See what they told us:

Professor Jan Van Meerbeeck, ERS Thoracic Oncology Assembly Head

Q: What can professionals specialising in thoracic oncology expect to gain from taking part in this year's Congress?

A: Experts will cover the different aspects of diagnosis, screening and treatment and there will be challenging cases and posters on tumour biology.

Q: Is there a particular session in the thoracic oncology programme that should not be missed?

A: The session, ‘How to implement lung cancer screening in your hospital and country’ (scheduling details coming soon).

Dr Torsten Gerriet Blum, ERS Thoracic Oncology Assembly Secretary

Q: What in your opinion will be the popular topics in the thoracic oncology field during this year's Congress, and what will be particular highlight for you?

A: Besides most recent updates on lung cancer screening and solitary pulmonary nodule management, which are two of our key topics involving all pulmonologists, I am really looking forward to our interactive sessions in this new virtual ERS Congress format. The Lung Cancer Grand Round and Lungs on Fire with thrilling thoracic oncological cases cannot replace Vienna, but will certainly create a vivid and worthwhile atmosphere!

Dr Adrien Costantini, ERS Thoracic Oncology Assembly early career representative

Q: As an early-career professional with a focus on thoracic oncology, why is the upcoming Congress valuable to career development?

A: Thoracic oncology is an extremely active specialty with regards to innovative treatment strategies but also with regards to patient management. The ERS Congress with sessions such as the State-of-the-art session gives a comprehensive overview of current and future developments. I also particularly enjoy the Grand Round and Challenging Clinical Cases sessions as they allow great interaction, active participation and an immersive experience, putting you in the shoes of the clinician. After Congress, I usually come home with lots of new ideas, new viewpoints and my daily practice is, more often than not, improved.

Learn more about the ERS Thoracic Oncology Assembly

Back to 'Eight major respiratory topics'

View all programme highlights

Copyright © 2020 - ERS International Congress - European Respiratory Society. All Rights Reserved.